相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis
Marcello Tonelli et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Iron Supplementation and Erythropoiesis-Stimulatory Agents in the Treatment of Cancer Anemia
Paolo Pedrazzoli et al.
CANCER (2009)
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
Julia Bohlius et al.
LANCET (2009)
Characterization and Differentiation of Iron Status in Anemic Very Low Birth Weight Infants Using a Diagnostic Nomogram
David C. Kasper et al.
NEONATOLOGY (2009)
Intravenous iron: A useful therapeutic tool but not a panacea
Eirini Katodritou et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Intravenous iron: From anathema to standard of care
Michael Auerbach et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Should intravenous iron be the standard of care in oncology?
Michael Auerbach
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alfa administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia
Laurent Bastit et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alfa
Paolo Pedrazzoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Is intravenous iron supplementation with erythropoiesis-stimulating agents beneficial in cancer patients with anemia?
Julia Bohlius
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia
Stacy S Shord et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2008)
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology American Society of Clinical Oncology clinical practice guideline update
J. Douglas Rizzo et al.
BLOOD (2008)
Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma
Eirini Katodritou et al.
ANNALS OF HEMATOLOGY (2007)
Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the dialysis patients' response to IV iron with elevated ferritin (DRIVE) study
Daniel W. Coyne et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer:: 2006 update
C. Bokemeyer et al.
EUROPEAN JOURNAL OF CANCER (2007)
Prediction of the responsiveness to treatment with erythropoiesis-stimulating factors: A prospective clinical study in patients with solid tumors
Tilman Steinmetz et al.
ONCOLOGIST (2007)
Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy
David H. Henry et al.
ONCOLOGIST (2007)
Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients
Mahmoud El-Khatib et al.
NEPHROLOGY (2006)
Medical progress: Anemia of chronic disease
G Weiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial
M Auerbach et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer
C Bokemeyer et al.
EUROPEAN JOURNAL OF CANCER (2004)
Iron deficiency and erythropoiesis: New diagnostic approaches
C Brugnara
CLINICAL CHEMISTRY (2003)
Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production
M Cazzola et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology
JD Rizzo et al.
BLOOD (2002)
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines
IC Macdougall et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
A randomized trial of iron deficiency testing strategies in hemodialysis patients
S Fishbane et al.
KIDNEY INTERNATIONAL (2001)
Inflammation, serum C-reactive protein, and erythropoietin resistance
P Bárány
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
European Best Practice Guidelines 14-16 - Inadequate response to epoetin
WH Horl et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
分享论文
